Advance Care Planning for Older Latinos With Chronic Illness

October 7, 2023 updated by: Frances Nedjat-Haiem, San Diego State University

Advance Care Planning for Older Latinos With Chronic Illness: A Feasibility Study

The goal of this study is to test the feasibility of a randomized controlled trial to learn about implementation of an intervention model, Advance Care Planning I Plan (ACP-I Plan), among older Latinos with chronic illnesses in community settings.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The goal of this study is to test the feasibility of a randomized controlled trial to learn about implementation of an intervention model, Advance Care Planning I Plan (ACP-I Plan), among older Latinos with chronic illnesses in community settings.

The questions of this study seek to explore implementation of the intervention model:

  1. To evaluate feasibility, acceptability, and preliminary impact of ACP-I Plan to improve AD documentation and increase engagement in ACP communication with family and providers among older Latinos with chronic diseases (cancers and non-cancers); and
  2. To evaluate implementation of ACP-I Plan in a community setting and examine further need for adaption.

Participants will be randomized into two groups:

  1. ACP education consisting of

    • a brief social work screening,
    • an educational pamphlet,
    • advance directive forms (in English and Spanish), and
    • community resource materials (i.e., handout); and
  2. ACP education plus counseling consisting of

    • motivational interviewing
    • decisional support, and
    • patient navigation to address barriers We anticipate that ACP-I Plan will be feasibly and acceptable. Participants who receive ACP-I Plan will show 1) greater likelihood of documenting an AD, 2) greater importance of and concern for engaging in ACP communication with family members and providers, and 3) reduced distress at 4-week post intervention.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92182
        • San Diego State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 50 years old or older
  • Latino/Latina or Hispanic?
  • Have 1 or more chronic health conditions

Exclusion Criteria:

  • Schizophrenia
  • Schizoaffective Disorder
  • Dementia
  • Alzheimer's disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ACP education

ACP education consisting of

  • a brief social work screening,
  • an educational pamphlet,
  • advance directive forms (in English and Spanish), and
  • community resource materials (i.e., handout)
ACP-I Plan consisting of education, counseling, decisional support, and patient navigation
Experimental: ACP education plus counseling

ACP education plus counseling consisting of

  • a brief social work screening,
  • an educational pamphlet,
  • advance directive forms (in English and Spanish), and
  • community resource materials (i.e., handout);
  • motivational interviewing
  • decisional support, and
  • patient navigation to address barriers
ACP-I Plan consisting of education, counseling, decisional support, and patient navigation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention Feasibility
Time Frame: 12 months

Feasibility

We use benchmarks for feasibility.

  1. Number of Participants Recruited, and screening no more than 100 participants,
  2. tracking numbers of participants consented into the study,
  3. percent refused to participate and dropout, amount of time to screen participants and complete a baseline survey once consented into the study,
  4. ACP-I Plan intervention delivered for the first session <2 weeks from their recruitment and randomization date and second session <4 weeks from recruitment,
  5. identify missing data.
  6. Track the number of participants who indicate they returned a completed AD to their provider and/or talked with a family member regarding ACP.
12 months
Satisfaction with intervention
Time Frame: 1 month

Acceptability of the intervention

Satisfaction survey questions includes 14 questions using "I" statements and a 5-point Likert scale: Strongly Disagree to Strongly Agree). Improved scores at follow up indicate satisfaction of information delivery.

Reference

Lyon ME, Garvie PA, Briggs L, He J, McCarter R, D'Angelo LJJJopm. Development, feasibility, and acceptability of the Family/Adolescent-Centered (FACE) Advance Care Planning intervention for adolescents with HIV. 2009;12(4):363-372.

1 month
Retention and Attrition Rates
Time Frame: 12 months
Feasibility of recruitment and retention
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion Rates
Time Frame: 1 month

Self report yes/no completed an advance directive document.

We use the method that Douglas & Brown (2002) used ask about completion of advance directives at 2 points, baseline and 1-month follow-up. Questions have yes/no [Y/N], responses.

Reference Douglas R, Brown HN. Patients' attitudes toward advance directives. Journal of Nursing Scholarship.

2002;34(1):61-65.

We also use the Advance Directive Attitude Survey (ADAS) by Nolan has 16 items and asks questions (uses a 4-point Likert scale, Strongly Agree to Strongly Disagree with AD decision making). Sixteen questions are subscales and ask about: (a) opportunity for treatment choices, (b) effect of advance directives on the family, (c) effect of an AD on treatment, and (d) perception of illness.

Nolan MT, Bruder M. Patients' attitudes toward advance directives and end-of-life treatment decisions. Nursing outlook. 1997;45(5):204-208.

1 month
Communication Readiness Provider
Time Frame: 1 month

Barriers to ACP communication and readiness to talk with provider.

We use a barrier scale developed to identify Barriers to Communication about Advance Care Planning (Nedjat-Haiem, 2022) which has 19 questions and uses a scale from 0 to 4, asking how much of a concern is this for you? Readiness to engage in communication about ACP will be assessed by three yes/no questions that ask about: (1) fear of death and dying, (2) difficulty engaging in EOL care communication, and (3) worry about illness severity.

We also use a readiness scale (1-10) which asks: how ready are you to engage in ACP communication with your physician.

1 month
Communication Readiness Family
Time Frame: 1 month

Self Report yes/no - Readiness to talk with a family member

We also use one question to ask about about readiness using a scale (1-10) which asks: how ready are you to engage in ACP communication with your family member?

1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ayala, PhD, San Diego State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2022

Primary Completion (Actual)

April 16, 2023

Study Completion (Actual)

April 16, 2023

Study Registration Dates

First Submitted

November 21, 2022

First Submitted That Met QC Criteria

October 7, 2023

First Posted (Actual)

October 13, 2023

Study Record Updates

Last Update Posted (Actual)

October 13, 2023

Last Update Submitted That Met QC Criteria

October 7, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HS-2020-0175

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Clinical Trials on ACP-I Plan

Subscribe